| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | B |
| 3. Samples | A |
| 4. Measurand | A |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | A |
| 7. Steady State | A |
| 8. Outlier Analysis | C |
| 9. Normality | B |
| 10. Variance Homogeneity | C |
| 11. ANOVA | B |
| 12. CI | C |
| 13. No of Results | C |
| 14. Concentrations | A |
| 15. Total Score | C8,10,12,13 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | Carcinoembryonic antigen (CEA) |
| Unit | ug / L |
| Overall Analytical Principle Method | Immunoassay; Other |
| Number of Subjects | 9 |
| Number of Subjects included in BV estimation | 9 |
| Ethinicity | Unknown |
| Age Mean / Median | 61.0 |
| Age Min | |
| Age Max | |
| Age SD | |
| Number of Males | 5 |
| Number of Females | 4 |
| State of Well Being |
Non-healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 2 |
| Study Duration Units | Day |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 6 |
| Interval Units | Hour |
| Sampling Times | Start Time:
08:00
End Time: 18:00 |
| Number of Samples | 6 |
| Average Number of Samples Used for BV Estimation | 6.0 |
| Average Number of Replicates | 1.0 |
| Estimates of CVi | 10.9 |
| Calculated Confidence Intervals of CVi | Lower: 5.38, Upper: 14.12 |
| Estimates of CVg | 178.0 |
| Calculated Confidence Intervals of CVg | Lower: 122.38, Upper: 325.04 |
| Analytical CV | 4.3 |
| Calculated Confidence Intervals of Analytical CV | Lower: 2.68, Upper: 10.55 |
| Measurand Mean | 7.4 |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |